Orix CORP

Shuji Irie, a Director and Officer of ORIX Corp, reported the acquisition of share-based compensation units convertible into common stock.

Takashi Otsuka, ORIX Corp's Chief Risk Officer, acquired 13,159 shares of common stock and was granted 15,750 share-based compensation points.

ORIX Corporation Director Chikatomo Hodo reported the acquisition of 2,000 share-based compensation points convertible to common stock.

ORIX Corporation Director Noriyuki Yanagawa reported the acquisition of 2,000 share-based compensation points, convertible to common stock upon retirement.

Masataka Yamada of ORIX Corporation reports the acquisition of share-based compensation, representing rights to receive common stock upon retirement.

Satoru Matsuzaki, a Director and Officer of ORIX Corporation, reported the acquisition of 6,579 shares of common stock and the grant of 51,910 share-based compensation points.

Orix Corp reported 0 holdings worth $0 for the period ended June 30, 2026.

ORIX Corp has filed a Form 13F-NT for the quarter ended March 31, 2026, indicating no new holdings are reported in this specific filing.

ORIX Corp has filed a 13F Notice for the quarter ended December 31, 2025, indicating its holdings are reported by other managers.

ORIX Corp filed an amended 13F report for Q2 2025, restating its holdings which include a significant stake in Ormat Technologies Inc.

ORIX Corp filed its 13F-HR report, revealing a significant sole investment of 379,767 shares in ORMAT Technologies Inc. valued at $36.5 million as of September 30, 2025.

ORIX Corporation has filed its 13F-HR report, revealing a significant holding of 2,976,077 shares in ORMAT Technologies Inc., valued at approximately $249.3 million as of June 30, 2025.

Sumitomo Mitsui Trust Group, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.0% of ORIX Corporation's common stock as of June 30, 2026.